<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628560</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00100105</org_study_id>
    <nct_id>NCT03628560</nct_id>
  </id_info>
  <brief_title>Alternate Methodology of Pulse Oximeter Validation</brief_title>
  <official_title>Alternate Methodology of Pulse Oximeter Validation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine if the replacement of the measured arterial blood oxygen saturation&#xD;
      with expired (end-tidal) oxygen value is an acceptable method to calculate the accuracy of&#xD;
      pulse oximeters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulse oximeters are non-invasive devices that use light to display an estimate (denoted by&#xD;
      SpO2) of the true arterial blood oxygen saturation (SaO2). The accuracy of the pulse oximeter&#xD;
      is determined from desaturation sequences (reduction in SpO2 from 100 to 70%) performed in&#xD;
      healthy volunteers. The current standard desaturation sequence is a step-wise reduction in 5%&#xD;
      SpO2 increments, achieved by reduction in inspired oxygen delivered by a gas blender such as&#xD;
      the ROBD (Reduced Oxygen Breathing Device). This mixes oxygen and nitrogen (components of&#xD;
      air) to produce the desired gas mixture. Throughout the desaturation sequence arterial blood&#xD;
      gas samples are drawn at each step. The blood gas samples are processed through a co-oximeter&#xD;
      to measure the SaO2. For each SaO2 measurement there will be a corresponding SpO2 recorded.&#xD;
      All data points from all subjects are amalgamated together to allow calculation of how well&#xD;
      SpO2 corresponds to the SaO2 throughout the range of 70 - 100% oxygen saturation. Accuracy,&#xD;
      A[RMS], is the unit of measure and this incorporates both bias and precision.&#xD;
&#xD;
      When the ROBD is used in a desaturation sequence, the subjects' arterial blood carbon dioxide&#xD;
      (CO2) level will initially be normal (normocapnia). With the reduction in SpO2 during the&#xD;
      desaturation sequence, the subjects' breathing rate will increase and this will cause the a&#xD;
      physiological reduction in the blood CO2 value (hypocapnia). The extent of hypocapnia will&#xD;
      vary from one subject to another. It is not known whether the presence of hypocapnia may have&#xD;
      an effect upon the accuracy measurement.&#xD;
&#xD;
      The RespirAct is a gas blender which, in contrast to the ROBD, can control both the oxygen&#xD;
      level as well as the carbon dioxide level. The end-tidal oxygen level (PAO2) is continuously&#xD;
      displayed by the RespirAct during the desaturation sequence. The PAO2 closely approximates to&#xD;
      arterial blood oxygen (PaO2) - the degree of closeness will be measured in the study. Through&#xD;
      an accepted formula, the SaO2 can be derived from the measured PAO2. The derived SaO2 values&#xD;
      can subsequently be used to measure the accuracy of the pulse oximeter. This A[RMS] can then&#xD;
      be compared with the A[RMS] calculated from the blood gas co-oximeter PaO2 / SaO2 values. If&#xD;
      the accuracies are comparable then this would remove the need for arterial line placement&#xD;
      during pulse oximeter validation studies.&#xD;
&#xD;
      Eligible healthy volunteers will complete five (5) oxygen desaturation sequences with&#xD;
      adjustment of sequence type and/or CO2 level. Two sequences will be delivered by step-wise&#xD;
      reduction and two will be delivered by gradual slope. Two sequences will be delivered at&#xD;
      normocapnia and two will be delivered at hypocapnia values. The ROBD sequence will be a&#xD;
      step-wise reduction with CO2 value set by the subjects' own breathing control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Pending equipment repair&#xD;
  </why_stopped>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of FDA-approved pulse oximeter when calculated with RespirAct-derived end-tidal PAO2 values and with co-oximeter measured arterial PaO2 values</measure>
    <time_frame>1 study day</time_frame>
    <description>The unit of measure of accuracy is called A[RMS] and is a composite value of bias and precision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PAO2 values</measure>
    <time_frame>1 study day</time_frame>
    <description>RespirAct-derived end-tidal PAO2 values with co-oximeter measured arterial PaO2 values</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy, A[RMS], when a step-wise desaturation sequence is used against a slope desaturation sequence.</measure>
    <time_frame>1 study day</time_frame>
    <description>The unit of measure of accuracy is called ARMS and is a composite value of bias and precision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of PaCO2 (hypocapnia versus normocapnia)</measure>
    <time_frame>1 study day</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypoxemia</condition>
  <condition>Desaturation of Blood</condition>
  <arm_group>
    <arm_group_label>RespirAct Step-Wise Normocapnia desaturation sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction in oxygen saturation 100 to 70% in approximate 5% steps.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RespirAct Slope Normocapnia desaturation sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction in oxygen saturation 100 to 70% as gradual slope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RespirAct Step-Wise Hypocapnia desaturation sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction in oxygen saturation 100 to 70% in approximate 5% steps.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RespirAct Slope Hypocapnia desaturation sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction in oxygen saturation 100 to 70% as gradual slope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ROBD Step-Wise desaturation sequence</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ROBD = Reduced Oxygen Breathing Device. Reduction in oxygen saturation 100 to 70% in approximate 5% steps. This represents the standard type of desaturation sequence for pulse oximeter accuracy testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RespirAct Step-Wise Normocapnia desaturation sequence</intervention_name>
    <description>Blood carbon dioxide controlled at normal value (normocapnia).</description>
    <arm_group_label>RespirAct Step-Wise Normocapnia desaturation sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RespirAct Slope Normocapnia desaturation sequence</intervention_name>
    <description>Blood carbon dioxide controlled at normal value (normocapnia).</description>
    <arm_group_label>RespirAct Slope Normocapnia desaturation sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RespirAct Step-Wise Hypocapnia desaturation sequence</intervention_name>
    <description>Blood carbon dioxide controlled at lower than normal value (hypocapnia).</description>
    <arm_group_label>RespirAct Step-Wise Hypocapnia desaturation sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RespirAct Slope Hypocapnia desaturation sequence</intervention_name>
    <description>Blood carbon dioxide controlled at lower than normal value (hypocapnia).</description>
    <arm_group_label>RespirAct Slope Hypocapnia desaturation sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ROBD Step-Wise desaturation sequence</intervention_name>
    <description>Blood carbon dioxide is controlled at normal or lower value by subject's own breathing rate.</description>
    <arm_group_label>ROBD Step-Wise desaturation sequence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 - 50 years&#xD;
&#xD;
          -  Subject is willing to provide written informed consent and is able to comply with&#xD;
             anticipated study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index (BMI) &lt; 18.0 or &gt; 30.0&#xD;
&#xD;
          -  Known significant respiratory, cardiovascular or medical condition that precludes&#xD;
             study participation as judged by investigator&#xD;
&#xD;
          -  Anemia [hemoglobin value below lower range of normal for gender]&#xD;
&#xD;
          -  Abnormal hemoglobin electrophoresis result&#xD;
&#xD;
          -  Exposure to nicotine [positive test at screening or study day]&#xD;
&#xD;
          -  Abnormal drug screen [positive test at screening or on day of study]&#xD;
&#xD;
          -  Positive pregnancy test for females [serum test at screening; urine test on study day]&#xD;
&#xD;
          -  Abnormal Allen's test for collateral circulation&#xD;
&#xD;
          -  Abnormal Electrocardiogram&#xD;
&#xD;
          -  Abnormal Pulmonary Function Test&#xD;
&#xD;
          -  Abnormal venous blood gas result&#xD;
&#xD;
          -  Intolerance of facemask&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David B MacLeod, FRCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://anesthesiology.duke.edu/?page_id=845005</url>
    <description>Human Pharmacology &amp; Physiology Lab at Duke University</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy volunteer</keyword>
  <keyword>Oximetry</keyword>
  <keyword>Pulse oximeter</keyword>
  <keyword>Hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

